Add Company
Join Now

Barrier Therapeutics Revenue and Competitors

License our Company Data API

USA

Location

N/A

Total Funding

Pharma

Industry

Estimated Revenue & Valuation

  • Barrier Therapeutics's estimated annual revenue is currently $10.1M per year.(i)
  • Barrier Therapeutics's estimated revenue per employee is $201,000

Employee Data

  • Barrier Therapeutics has 50 Employees.(i)
  • Barrier Therapeutics grew their employee count by 0% last year.

Barrier Therapeutics's People

NameTitleEmail/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$46.2M2305%N/AN/A
#2
$43.8M21821%N/AN/A
#3
$57.1M28426%N/AN/A
#4
$24.5M1223%N/AN/A
#5
$52.9M26313%N/AN/A
#6
$24.7M12313%N/AN/A
#7
$1.8M180%$114.3MN/A
#8
$7.2M36-20%N/AN/A
#9
$13.7M68-7%N/AN/A
#10
$7.6M39-13%$123.9MN/A
Add Company

What Is Barrier Therapeutics?

was a pharmaceutical company, engaged in the discovery, development, and commercialization of pharmaceutical products in the field of dermatology. Marketed products are Vusion, Xolegel and Solagé It was acquired by Stiefel Laboratories in August 2008.

keywords:N/A

N/A

Total Funding

50

Number of Employees

$10.1M

Revenue (est)

0%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$10.8M500%N/A
#2
$9.8M50-15%N/A
#3
$3.5M500%N/A
#4
$11M500%N/A
#5
$7.2M504%N/A